Weight-loss drugs aren't a magic bullet. Lifestyle changes are key to lasting health
Briefly

Weight-loss medicines like semaglutide and tirzepatide have become popular options for people struggling to lose weight. They have been shown to help patients lose 10% to 20% of their body weight.
The medicines, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), work by slowing stomach-emptying and decreasing appetite.
These medications were originally developed for Type 2 diabetes but have been found to have additional benefits. Semaglutide has been shown to reduce major adverse cardiac events by 20% in overweight or obese individuals with cardiovascular disease.
In December, we also learned that in people with cardiovascular disease who are overweight or obese, semaglutide appears to reduce major adverse cardiac events by 20%.
Read at www.npr.org
[
add
]
[
|
|
]
more Wellness Briefly
[ Load more ]